uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Peramivir induces resistance substitution H275Y in influenza A/H1N1 virus infecting Mallards exposed to low level of the drug in water
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
The Peter Doherty Institute for Infection and Immunity, WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia.
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-341698OAI: oai:DiVA.org:uu-341698DiVA, id: diva2:1182310
Available from: 2018-02-12 Created: 2018-02-12 Last updated: 2018-02-14
In thesis
1. Prescription – Pollution – Poo – Pandemics - Priorities: Neuraminidase Inhibitors from an Environmental Resistance Development Perspective
Open this publication in new window or tab >>Prescription – Pollution – Poo – Pandemics - Priorities: Neuraminidase Inhibitors from an Environmental Resistance Development Perspective
2018 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The natural Influenza A virus (IAV) host is waterfowl. Human IAV is treated with neuraminidase inhibitors (NAIs), which are stockpiled worldwide in case of an IAV pandemic. As the drugs escape regular waste water treatment, they can be detected in river waters.

We hypothesize that exposure of low pathogenic avian IAV (LPAIV) infecting Mallards to NAIs in the water promotes development of resistance that can persist in the absence of drugs. Dissemination of resistance genes to humans pose a health risk, particularly if incorporated into a pandemic IAV.

To test the hypothesis, LPAIVs of both NA phylogenetic groups were assessed in an in vivo Mallard model by inoculation and exposure of birds to NAI in their water. In previous work in the model, the oseltamivir-resistant H275Y mutation emerged in H1N1 in response to oseltamivir exposure and persisted without drug pressure.

In this thesis, a H7N9 was exposed to oseltamivir and a H1N1 and H4N2 to zanamivir and peramivir. Furthermore, a H1N1 with the H275Y mutation was exposed to zanamivir in order to assess the additional development of zanamivir resistance and the persistence of the H275Y mutation in the presence of zanamivir.

Several substitutions reducing drug susceptibility emerged; I222T in H7N9, V116A, A138V, T157I, R152K and D199G in H1N1 exposed to zanamivir, H275N and E119G in H4N2 exposed to zanamivir and 275Y in H4N2 exposed to peramivir. None of the tested zanamivir-induced substitutions persisted in the absence of drug, indicating lower risk of circulation of these substitutions in the wild as compared to oseltamivir.

There is a risk of NAI resistance emerging in LPAIVs of Mallards exposed to NAIs in the water. Zanamivir appears to be the best option from an environmental perspective. Drug concentrations in the Mallard model are mostly higher than the concentrations detected in rivers, but are in the same magnitude regarding OC and an H1N1 LPAIV. Given the importance of NAIs as the first line of defence in the event of a pandemic, this is of public health concern. Surveillance of LPAIV in waterfowl, prudent use of NAIs and waste water treatment improvements are important measures to mitigate the risk.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2018. p. 74
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 1428
Keywords
Influenza A virus, neuraminidase inhibitor, resistance, environmental, Mallard, zanamivir, avian influenza
National Category
Medical and Health Sciences Agricultural and Veterinary sciences
Identifiers
urn:nbn:se:uu:diva-341701 (URN)978-91-513-0237-9 (ISBN)
Public defence
2018-03-29, Auditorium Minus, Museum Gustavianum, Akademigatan 3, Uppsala, 09:15 (Swedish)
Opponent
Supervisors
Available from: 2018-03-07 Created: 2018-02-14 Last updated: 2018-04-03

Open Access in DiVA

No full text in DiVA

By organisation
Department of Medical SciencesDepartment of Medical Biochemistry and Microbiology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf